All posts tagged
British Researchers “Calm Down” Macrophages to treat Inflammation
French Biotech Enters New Agreement to Advance its IBD Immunotherapy
More News! Smart Lens looks More Distant & a Pollen Allergy Cure?
This Biotech in London is Going After the Most Common Eye Disease
French Immunotherapy Partners fight against Autoimmune Disorders
Galapagos gets another Milestone Payment from Gilead
Boehringer Ingelheim Gets €540M upfront for the next Potential Antibody Blockbuster
For when it actually is Lupus: New Autoimmune Crisis Drug reaches Human Trials
Pfizer pursues AM-Pharma’s treatment against Inflammatory Diseases
Celltrion launches world’s first biosimilar monoclonal antibody in 12 new European markets
Unstoppable Ferring after the Acquisition of a novel Oral Drug Delivery Technology
Will 4D Pharma be UK’s next Microbiome leader?
Labiotech UG, All Rights Reserved -
Send this to friend